October 7 - 9, 2021 Geneva (Switzerland)
![]() |
![]() |
![]() |
![]() |
PO1-001 | Evaluation of efficacy and safety of splenic artery embolization versus endoscopic treatment for secondary prophylaxis of variceal bleedings | Sergii Kozlov | ![]() |
![]() |
|||
PO2-001 | Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukaemia | Federico Ravaioli | ![]() |
![]() |
|||
PO6-001 | Upper gastrointestinal bleding in cirrhosis: predictive factors of recurence | Fatma Ben Farhat | ![]() |
![]() |
|||
PO5-001 | The efficacies and risks comparisons between direct oral anticoagulants and low molecular weight heparin or warfarin in both cirrhotic and non-cirrhotic portal vein thrombosis patients: systematic review and meta-analysis | Boby Pratama Putra | ![]() |
![]() |
|||
PO4-001 | Prevalence and associated factors of ascitic decompensation in patients with acute variceal bleeding | Myriam Ayari | ![]() |
![]() |
|||
PO8-001 | A non-invasive diagnosis of oesophageal varices in patients with compensated liver cirrhosis | AbdelGhani Atef Abdel Ghani Badran | ![]() |
![]() |
|||
PO7-001 | Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure | Alberto Zanetto | ![]() |
![]() |
|||
PO4-002 | Liver fibrosis markers as predictors of recurrent variceal bleeding in cirrhosis | Fatma Ben Farhat | ![]() |
![]() |
|||
PO7-002 | Natural history and clinical impact of non-neoplastic portal vein thrombosis in cirrhotics with hepatocellular carcinoma | SARAH SHALABY | ![]() |
![]() |
|||
PO8-002 | The associations among von willebrand factor, ADAMTS13, and factor VIII with non-malignant portal vein thrombosis incidence: systematic review and meta-analysis | Boby Pratama Putra | ![]() |
![]() |
|||
PO3-002 | Non-cirrhotic portal hypertension in people living with HIV infection: significant progression to end stage liver disease | Kate Childs | ![]() |
![]() |
|||
PO5-002 | Improvement in portal vein thrombosis clot volume is associated with improved overall survival in cirrhosis patients with PVT: A justification for treatment? | Lauren Carlini | ![]() |
![]() |
|||
PO1-002 | Portal vein thrombosis is not associated with increased mortality or excess decompensation in cirrhosis patients: A case control study | Lauren Carlini | ![]() |
![]() |
|||
PO2-002 | A rare cause of acute liver failure associated with acquired thrombophilia | ZANIL YOONUS NIZAR | ![]() |
![]() |
|||
PO6-002 | Thrombophilia profile in patients with extrahepatic portal vein obstruction (EHPVO) | Akash Shukla | ![]() |
![]() |
|||
PO3-003 | Non-cirrhotic portal hypertension in a patient with protein C and S deficiency. A case report | Faisal Nawaz | ![]() |
![]() |
|||
PO1-003 | Performance of ten non-invasive liver function tests in predicting six-week mortality in acute variceal bleeding | Nouha Trad | ![]() |
![]() |
|||
PO6-003 | Impact of prothrombin and factor V leiden mutations on the progression of fibrosis in patients with chronic hepatitis C | Eman Abdelsameea | ![]() |
![]() |
|||
PO7-003 | Invasive and non-invasive staging of Fontan-associated liver disease: The VALDIG prospective Fonliver cohort | Luis Téllez | ![]() |
![]() |
|||
PO5-003 | Impact of asymptomatic superior mesenteric vein thrombosis on the survival of patients with liver cirrhosis | Le Wang | ![]() |
![]() |
|||
PO4-003 | Association of C-type lectin-like receptor 2 and galectin-1 with portal venous system thrombosis in liver cirrhosis | shixue xu | ![]() |
![]() |
|||
PO2-003 | Prediction of esophageal variceal rebleeding in cirrhosis using the P2/MS noninvasive index based on complete blood counts | Fatma Ben Farhat | ![]() |
![]() |
|||
PO4-004 | Performance of albumin, bilirubin and platelets criteria to predict the absence of high-risk esophageal varices | Nouha Trad | ![]() |
![]() |
|||
PO8-004 | Portosinusoidal vascular disease and Common variable immunodeficiency | Berta Bartrolí Alabau | ![]() |
![]() |
|||
PO5-004 | Safety and efficacy of direct oral anticoagulants (DOACs) in Budd-Chiari Syndrome (BCS) - an Austrian multicenter study | Bernhard Scheiner | ![]() |
![]() |
|||
PO3-004 | Red cell distribution width as a predictor of outcome in hospitalized cirrhotic patients | Mohamed Abdel-Samiee | ![]() |
![]() |
|||
PO1-004 | The peculiarities of the management of a patient with ischemic stroke in Rendu-Osler-Weber disease | Antonina Antonenko | ![]() |
![]() |
|||
PO7-004 | High plasma thrombomodulin level indicated poor prognostic of liver cirrhosis: A prospective cohort study | Jing Zhang | ![]() |
![]() |
|||
PO6-004 | Divergencies in macrophage activation markers soluble CD163 and mannose receptor in patients with non-cirrhotic and cirrhotic portal hypertension | Henning Grnbk | ![]() |
![]() |
|||
PO2-005 | Assessing the bleeding risk after liver biopsy using new clinical and biological tools : a prospective analysis of 306 procedures | alix riescher | ![]() |
![]() |
|||
PO4-005 | Performance of bleeding risk scores in predicting mortality in acute variceal bleeding | Nouha Trad | ![]() |
![]() |
|||
PO8-005 | Potential role of cellular component of blood in ADP induced platelet aggregation | Dermot Cox | ![]() |
![]() |
|||
PO5-005 | Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease | Katharina Pomej | ![]() |
![]() |
|||
PO7-005 | Impact of porto-systemic vein shunting on non-alcoholic liver disease and hepatocellular carcinoma development in a high fat diet mouse model | Andrea Peloso | ![]() |
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|